EX-8.1 4 azn-20211231xex8d1.htm EXHIBIT 8.1

Exhibit 8.1

GROUP SUBSIDIARIES*

At December 31, 2021

    

Country

    

Percentage of voting
share capital held

Wholly owned subsidiaries

 

 

Alexion Pharmaceuticals, Inc.

United States

100

Alexion Pharma International Operations Unlimited Company

Ireland

100

AstraZeneca AB

Sweden

100

AstraZeneca Biotech AB

Sweden

100

AstraZeneca Dunkerque Production SCS

France

100

AstraZeneca Finance and Holdings, Inc.

United States

100

AstraZeneca Intermediate Holdings Limited

England

100

AstraZeneca Pharmaceuticals Co., Limited

China

100

AstraZeneca Pharmaceutical (China) Co. Limited

China

100

AstraZeneca Treasury Limited

England

100

AstraZeneca UK Limited

England

100

AstraZeneca (Wuxi) Trading Co. Ltd

China

100

IPR Pharmaceuticals, Inc.

Puerto Rico

100

KuDOS Pharmaceuticals Limited

United Kingdom

100

MedImmune, LLC

United States

100


Subsidiary companies which would be deemed to be a “significant subsidiary” in accordance with rule 1-02(w) of Regulation S-X as at December 31, 2021.